Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial

Melissa Cambron, Jop Mostert, Patrick Haentjens, Marie D'Hooghe, Guy Nagels, Barbara Willekens, Dorothea Heersema, Jan Debruyne, Wim Van Hecke, Luc Algoed, Nina De Klippel, Erwin Fosselle, Guy Laureys, Henri Merckx, Bart Van Wijmeersch, Ludo Vanopdenbosch, Wim Verhagen, Raymond Hupperts, Gerald Hengstman, Veronique MichielsAnnick Van Merhaegen-Wieleman, Jacques De Keyser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number37
JournalTrials
Volume15
DOIs
Publication statusPublished - 25 Jan 2014

Keywords

  • Multiple sclerosis
  • Primary progressive
  • Secondary progressive
  • Clinical trial
  • Fluoxetine
  • Neuroprotection

Cite this